Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet’s DiseaseLu Li, Wenjie Zheng, Jinjing Liu et al.|Frontiers in Immunology|2021Cited by 60
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Xiaofeng Zeng, Lei Yang et al.|Annals of the Rheumatic Diseases|2025Cited by 17
Correction: Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behcet’s diseaseXiuhua Wu, Wenjie Zheng, Zhimian Wang et al.|Arthritis Research & Therapy|2022Cited by 4
Defective neutrophil-derived exosomes facilitate macrophage activation through miR-122-5p in Behçet’s diseaseXin Yu, Wenjie Zheng, Menghao Zhang et al.|Nature Communications|2025Cited by 2